Britain's Wellcome Trust said that clinical trials it was funding for a new Ebola treatment in Liberia were halted on Tuesday due to a fall in new cases. "The current position is that there is no realistic prospect of the trial enrolling sufficient patients to be able to reach a conclusion about the efficacy of the drug," the Wellcome Trust, Britain's biggest scientific research charity, said in a statement. The Wellcome Trust said the decision was taken on Tuesday after the pharmaceutical company Chimerix, which manufactures the brincidofovir treatment, said it was withdrawing from the trial on Friday. The first large-scale trials of two Ebola vaccines -- GlaxoSmithKline's Chad3-EBO-Z and rVSV-ZEBOV, manufactured by Merck and Newlink -- began in Liberia on Monday.
via Health News Headlines - Yahoo News http://ift.tt/16tAQ4M
No comments:
Post a Comment